TN2014000401A1 - Microrna compounds and methods for modulating mir-21 activity - Google Patents
Microrna compounds and methods for modulating mir-21 activityInfo
- Publication number
- TN2014000401A1 TN2014000401A1 TNP2014000401A TN2014000401A TN2014000401A1 TN 2014000401 A1 TN2014000401 A1 TN 2014000401A1 TN P2014000401 A TNP2014000401 A TN P2014000401A TN 2014000401 A TN2014000401 A TN 2014000401A TN 2014000401 A1 TN2014000401 A1 TN 2014000401A1
- Authority
- TN
- Tunisia
- Prior art keywords
- activity
- mir
- methods
- compositions
- modulating mir
- Prior art date
Links
Abstract
Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361779913P | 2013-03-13 | 2013-03-13 | |
PCT/US2013/037913 WO2013163258A1 (en) | 2012-04-25 | 2013-04-24 | Microrna compounds and methods for modulating mir-21 activity |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2014000401A1 true TN2014000401A1 (en) | 2015-12-21 |
Family
ID=55447253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2014000401A TN2014000401A1 (en) | 2013-03-13 | 2014-09-24 | Microrna compounds and methods for modulating mir-21 activity |
Country Status (1)
Country | Link |
---|---|
TN (1) | TN2014000401A1 (en) |
-
2014
- 2014-09-24 TN TNP2014000401A patent/TN2014000401A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014502387A1 (en) | Microrna compounds and methods for modulating mir-21 activity | |
MX2019003089A (en) | Microrna compounds and methods for modulating mir-21 activity. | |
AU2018236800B2 (en) | DNA-PK inhibitors | |
NZ724691A (en) | Quinoline derivatives as smo inhibitors | |
MX2021014128A (en) | Polymorphs of selinexor. | |
PH12014502513A1 (en) | Nampt inhibitors | |
MX2014013752A (en) | Nampt inhibitors. | |
NZ755605A (en) | Compositions for modulating tau expression | |
MX2016003486A (en) | Glucosylceramide synthase inhibitors for the treatment of diseases. | |
MX2021014663A (en) | Compound targeting il-23a and tnf-alpha and uses thereof. | |
MX2016002587A (en) | Modulation of prekallikrein (pkk) expression. | |
PH12016501462A1 (en) | Neprilysin inhibitors | |
PH12015502611A1 (en) | Heterocyclic compounds as hedgehog signaling pathway inhibitors | |
MX348311B (en) | Nampt inhibitors. | |
MX2014013758A (en) | Thiazolecarboxamide derivatives for use as nampt inhibitors. | |
MX2017011018A (en) | Inhibition of olig2 activity. | |
MD20160111A2 (en) | Cycloalkyl-linked diheterocycle derivatives | |
TN2014000401A1 (en) | Microrna compounds and methods for modulating mir-21 activity | |
NZ750581A (en) | Compositions and methods for treating neurodegenerative diseases and cardiomyopathy | |
NZ767083A (en) | Polymorphs of selinexor |